Table. Demographic and clinical characteristics of 5 patients with culture-confirmed plague (Yersina pestis infection) who were treated successfully with oral ciprofloxacin, Uganda, 2011–2014.
Patient no. | Age, y/sex | Length of illness, d* | Symptoms | Laboratory evidence | Ciprofloxacin dose, mg† |
---|---|---|---|---|---|
1 | 10/F | 7 | Fever, left axillary bubo | Bubo, blood cultures positive | 250 |
2 | 52/F | 4 | Fever, right axillary bubo | Bubo, blood cultures positive | 650 |
3 | 27/F | 1 | Fever, left inguinal bubo | Bubo, blood cultures positive | 750 |
4 | 36/M | 1 | Fever, left axillary bubo | Blood culture positive | 625 |
5 | 13/M | 6 | Fever, chest pain, cough, blood-tinged sputum | Sputum culture positive, blood culture negative | 375 |
*At time treatment was sought. †Orally, twice daily; ≈15 mg/kg bodyweight with a maximum of 750 mg.